Bayesian Capital Management’s GoodRx Holdings GDRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.2K | Buy |
+13,900
| New | +$69.2K | 0.01% | 500 |
|
|
2024
Q2 | – | Sell |
-13,868
| Closed | -$98.5K | – | 879 |
|
|
2024
Q1 | $98.5K | Sell |
13,868
-27,100
| -66% | -$192K | 0.01% | 714 |
|
|
2023
Q4 | $274K | Sell |
40,968
-14,400
| -26% | -$96.5K | 0.03% | 534 |
|
|
2023
Q3 | $312K | Buy |
+55,368
| New | +$312K | 0.04% | 464 |
|
|
2023
Q2 | – | Sell |
-70,139
| Closed | -$438K | – | 888 |
|
|
2023
Q1 | $438K | Buy |
70,139
+15,800
| +29% | +$98.8K | 0.05% | 430 |
|
|
2022
Q4 | $253K | Buy |
+54,339
| New | +$253K | 0.04% | 540 |
|
|
2021
Q3 | – | Sell |
-6,398
| Closed | -$230K | – | 444 |
|
|
2021
Q2 | $230K | Buy |
+6,398
| New | +$230K | 0.06% | 341 |
|